Historical record - last NADAC effective date: 1/17/2018
Product Information
ERY-TAB DR 333 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $8.5150 per EA under NDC 24338012413. Its NADAC has been published 261 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
333 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338012413
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
1/17/2018
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298FDA Approved
Before 1982
TE Code
AB
On Market Since
4/18/2011
Pharmacological Classes
Price Statistics
The NADAC for ERY-TAB DR 333 MG TABLET has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 308.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.5150 per EA |
|---|---|
| All-time high | $8.5150 (Jan 16, 2019) |
| All-time low | $2.0860 (Nov 28, 2013) |
| Median price | $7.3763 |
| Average price | $6.3174 |
| Largest weekly change | +44.4% (May 21, 2014) |
| Weeks tracked | 261 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+308.2%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERY-TAB DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 333 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $8.5150 per EA (NDC 24338012413), effective Jan 16, 2019.
How has the price of ERY-TAB DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERY-TAB DR 333 MG TABLET has risen 308.2%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERY-TAB DR 333 MG TABLET?
Since Nov 28, 2013, the NADAC for ERY-TAB DR 333 MG TABLET has ranged from a low of $2.0860 (Nov 28, 2013) to a high of $8.5150 (Jan 16, 2019), with a median of $7.3763 per EA.
Are there cheaper alternatives to ERY-TAB DR 333 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN DR 333 MG TABLET, is $3.5825 per EA — about 58% below ERY-TAB DR 333 MG TABLET.
Who manufactures ERY-TAB DR 333 MG TABLET?
ERY-TAB DR 333 MG TABLET (NDC 24338012413) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.